Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Standard BioTools Inc. (LAB) had Earnings per Share (EPS) (Basic) of $-0.07 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$20.10M |
|
$-26.76M |
|
$9.57M |
|
$10.54M |
|
$45.49M |
|
$-25.39M |
|
$3.95M |
|
$-21.43M |
|
$-21.43M |
|
$-21.52M |
|
$-21.52M |
|
$-26.76M |
|
$-21.52M |
|
$-25.39M |
|
$-25.32M |
|
390.88M |
|
390.88M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.07 |
$-0.07 |
|
| Balance Sheet Financials | |
$516.87M |
|
$15.30M |
|
$110.35M |
|
$627.22M |
|
$56.80M |
|
$0.30M |
|
$30.45M |
|
$87.25M |
|
$539.97M |
|
$539.97M |
|
$539.97M |
|
392.12M |
|
| Cash Flow Statement Financials | |
$-56.91M |
|
$205.50M |
|
$-0.18M |
|
$123.30M |
|
$272.12M |
|
$148.82M |
|
$12.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.10 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
52.40% |
|
-126.28% |
|
-126.28% |
|
-- |
|
-106.62% |
|
-133.10% |
|
$-57.82M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.56 |
|
1.28 |
|
70.49 |
|
-3.99% |
|
-3.99% |
|
-3.43% |
|
-3.98% |
|
$1.38 |
|
$-0.15 |
|
$-0.15 |
|